Healthways Inc. (HWAY) Given Average Rating of “Buy” by Analysts
Shares of Healthways Inc. (NASDAQ:HWAY) have received an average rating of “Buy” from the seven brokerages that are covering the stock. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $26.50.
Several brokerages recently issued reports on HWAY. Zacks Investment Research cut Healthways from a “buy” rating to a “hold” rating in a research note on Tuesday, September 20th. FBR & Co raised their price objective on Healthways from $16.00 to $21.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 10th. Barrington Research restated an “outperform” rating and set a $30.00 price objective (up from $29.00) on shares of Healthways in a research note on Thursday, October 13th. Barclays PLC upgraded Healthways from an “underweight” rating to an “equal weight” rating and raised their price objective for the stock from $12.00 to $27.00 in a research note on Monday, August 22nd. Finally, Oppenheimer Holdings Inc. upgraded Healthways to an “outperform” rating and set a $27.00 price objective on the stock in a research note on Sunday, August 14th.
In other Healthways news, Director Mary Jane England sold 3,816 shares of the firm’s stock in a transaction on Friday, August 26th. The stock was sold at an average price of $24.78, for a total value of $94,560.48. Following the sale, the director now directly owns 39,068 shares in the company, valued at $968,105.04. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 14.01% of the stock is owned by company insiders.
A number of large investors have recently bought and sold shares of HWAY. Acrospire Investment Management LLC boosted its stake in Healthways by 80.9% in the second quarter. Acrospire Investment Management LLC now owns 9,612 shares of the company’s stock worth $111,000 after buying an additional 4,300 shares during the last quarter. Quantitative Systematic Strategies LLC bought a new stake in shares of Healthways during the second quarter worth $118,000. Profund Advisors LLC boosted its stake in shares of Healthways by 4.5% in the second quarter. Profund Advisors LLC now owns 10,668 shares of the company’s stock worth $123,000 after buying an additional 456 shares in the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA boosted its stake in shares of Healthways by 7.6% in the second quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 11,685 shares of the company’s stock worth $135,000 after buying an additional 825 shares in the last quarter. Finally, KBC Group NV bought a new stake in shares of Healthways during the second quarter worth $147,000. Institutional investors own 92.60% of the company’s stock.
Healthways (NASDAQ:HWAY) opened at 25.92 on Friday. The firm’s market capitalization is $952.25 million. The stock’s 50 day moving average is $25.37 and its 200-day moving average is $16.75. Healthways has a 1-year low of $9.18 and a 1-year high of $27.30.
Healthways (NASDAQ:HWAY) last released its quarterly earnings results on Tuesday, August 9th. The company reported $0.54 earnings per share for the quarter, topping analysts’ consensus estimates of $0.01 by $0.53. Healthways had a negative net margin of 31.32% and a positive return on equity of 8.83%. The business earned $125 million during the quarter, compared to the consensus estimate of $186.88 million. During the same quarter last year, the company earned $0.11 earnings per share. The business’s quarterly revenue was up 10.2% compared to the same quarter last year. Equities research analysts forecast that Healthways will post $2.11 EPS for the current year.
Healthways Company Profile
Healthways, Inc (Healthways) provides network delivered solutions and population health management services that are designed to help people manage their wellbeing, thereby managing their health and productivity, and their health-related costs. The Company operates in the domestic and international segments, which are collectively known as the well-being improvement services segment.
Receive News & Ratings for Healthways Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related companies with MarketBeat.com's FREE daily email newsletter.